Tunstall completes acquisition of AMAC

Following the announcement on 22 September 2011, American Medical Alert Corp (Nasdaq: AMAC), a leading provider of remote health monitoring and 24/7 communication services that enhance care, accelerate response times, improve operational effectiveness and deliver sustainable patient services, is pleased to announce today the completion of its acquisition by Tunstall Healthcare Group, a leading telehealth and telecare provider based in the UK.

Jack Rhian, AMAC CEO commented, "Speaking on behalf of the management and staff of AMAC, we welcome and embrace the opportunity to serve as the foundational acquisition serving the North American territory on behalf of Tunstall. With Tunstall's exceptional engineering and manufacturing capabilities complementing AMAC's high touch communication and monitoring competence, AMAC will be uniquely positioned to serve the full spectrum of healthcare providers with Remote Patient Monitoring (RPM) devices and services as the US government and medical providers seek to provide accountable and cost efficient patient care."

"We are delighted that AMAC has become part of the Tunstall Healthcare Group. With this acquisition, Tunstall now has a strong North American business, including our successful business in Canada, that will enable us to grow in a market place increasingly requiring our products and services," said Gil Baldwin, Group CEO, Tunstall Healthcare Group. "I want to welcome all the employees and customers of AMAC to Tunstall and look forward to working together to continue to promote long-term health and independence and improve the quality of life for end-users of AMAC's technology and services."

With the acquisition of AMAC, the Tunstall Healthcare Group now has a turnover of £190M ($300m), employing c.1900 employees across the world. AMAC will continue to operate under its existing brand, with a growing emphasis on the provision of healthcare services.

Source:

American Medical Alert Corp

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare